This follow-up post makes 2022 predictions on the Covid-19 pandemic and public health. A previous post predicted the economy, politics, and…
Browsing: Curated GI articles
Dr. Markus Wilhelms, CEO and co-founder of MOWOOT, said: “The Breakthrough Device Designation is a significant milestone for our company…
When Teladoc first struck an $18.5 billion deal to acquire Livongo last year, experts predicted that it would herald an era of digital health mergers hitherto…
The belief that fecal matter contains harmful poisons is very old, Greek historian Herodotus reported that the ancient Egyptians used…
NEW YORK (Reuters Health) – Symptomatic strictures related to Crohn’s disease (CD) may respond to immunosuppressive drug therapy, with improvements…
Functional gastrointestinal disorders such as functional dyspepsia and irritable bowel syndrome are very common and show considerable alterations in gut-brain…
After an excellent debate on the future of telemedicine in GI in our most recent Perspectives column, we continue to…
Background and Aims Functional gastrointestinal disorders are common and costly to the healthcare system. In the MANTRA study, we demonstrated…
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and manage inflammatory bowel disease (IBD).…
CARLSBAD, Calif., January 5, 2022 (Newswire.com) – Virgo Surgical Video Solutions, the leading cloud video and artificial intelligence platform for endoscopic…